$MTEM
Molecular Templates, Inc.

2014 Q3 Form 10-Q Financial Statement

#000156459014004836 Filed on November 03, 2014

View on sec.gov

Income Statement

Concept 2014 Q3 2013 Q3
Revenue $3.680M $3.180M
YoY Change 15.72% 76.67%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.410M $2.050M
YoY Change 17.56% 17.82%
% of Gross Profit
Research & Development $8.906M $6.350M
YoY Change 40.25% 57.22%
% of Gross Profit
Depreciation & Amortization $300.0K $430.0K
YoY Change -30.23% 26.47%
% of Gross Profit
Operating Expenses $8.906M $8.401M
YoY Change 6.01% 45.35%
Operating Profit -$5.220M
YoY Change 31.06%
Interest Expense $30.00K $34.00K
YoY Change -11.76% 36.0%
% of Operating Profit
Other Income/Expense, Net -$340.0K $6.380M
YoY Change -105.33% 114.81%
Pretax Income -$7.947M $1.193M
YoY Change -766.14% -220.38%
Income Tax -$202.0K $17.00K
% Of Pretax Income 1.42%
Net Earnings -$7.745M $1.176M
YoY Change -758.59% -218.67%
Net Earnings / Revenue -210.46% 36.98%
Basic Earnings Per Share -$0.13 $0.02
Diluted Earnings Per Share -$0.15 -$0.08
COMMON SHARES
Basic Shares Outstanding 59.85M 58.54M
Diluted Shares Outstanding 61.49M 63.56M

Balance Sheet

Concept 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $67.70M $91.90M
YoY Change -26.33% 39.67%
Cash & Equivalents $11.20M $4.001M
Short-Term Investments $56.50M $87.90M
Other Short-Term Assets $1.900M $1.800M
YoY Change 5.56% 63.64%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $74.10M $99.28M
YoY Change -25.36% 17.58%
LONG-TERM ASSETS
Property, Plant & Equipment $600.0K $708.0K
YoY Change -15.25% -2.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $800.0K
YoY Change
Other Assets $1.200M $1.059M
YoY Change 13.31% 0.0%
Total Long-Term Assets $2.600M $1.767M
YoY Change 47.14% -1.12%
TOTAL ASSETS
Total Short-Term Assets $74.10M $99.28M
Total Long-Term Assets $2.600M $1.767M
Total Assets $76.70M $101.0M
YoY Change -24.09% 17.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.400M $1.375M
YoY Change 147.27% 86.06%
Accrued Expenses $6.800M $2.489M
YoY Change 173.2% 36.98%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $25.00M $24.88M
YoY Change 0.49% 53.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $72.70M $93.70M
YoY Change -22.41% -17.88%
Total Long-Term Liabilities $72.70M $93.70M
YoY Change -22.41% -17.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.00M $24.88M
Total Long-Term Liabilities $72.70M $93.70M
Total Liabilities $97.70M $118.5M
YoY Change -17.58% -9.02%
SHAREHOLDERS EQUITY
Retained Earnings -$344.1M
YoY Change -2.15%
Common Stock $326.6M
YoY Change 6.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$21.00M -$17.50M
YoY Change
Total Liabilities & Shareholders Equity $76.70M $101.0M
YoY Change -24.09% 17.2%

Cashflow Statement

Concept 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income -$7.745M $1.176M
YoY Change -758.59% -218.67%
Depreciation, Depletion And Amortization $300.0K $430.0K
YoY Change -30.23% 26.47%
Cash From Operating Activities -$11.16M -$7.420M
YoY Change 50.4% 229.78%
INVESTING ACTIVITIES
Capital Expenditures -$40.00K -$10.00K
YoY Change 300.0% -90.0%
Acquisitions
YoY Change
Other Investing Activities $11.24M $5.600M
YoY Change 100.71% 608.86%
Cash From Investing Activities $11.20M $5.580M
YoY Change 100.72% 720.59%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.740M 1.420M
YoY Change 233.8% -25.26%
NET CHANGE
Cash From Operating Activities -11.16M -7.420M
Cash From Investing Activities 11.20M 5.580M
Cash From Financing Activities 4.740M 1.420M
Net Change In Cash 4.780M -420.0K
YoY Change -1238.1% -227.27%
FREE CASH FLOW
Cash From Operating Activities -$11.16M -$7.420M
Capital Expenditures -$40.00K -$10.00K
Free Cash Flow -$11.12M -$7.410M
YoY Change 50.07% 244.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
686000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-2559000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
7781000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1689000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1059000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
14722000
CY2013Q4 us-gaap Assets
Assets
104118000
CY2014Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
56505000
CY2013Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
58390000
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3161000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Liabilities
Liabilities
127593000
CY2013Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
240000
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2407000
CY2013Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
16364000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-202000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
121000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-24000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
27000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15644000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20799000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1034000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1094000
us-gaap Share Based Compensation
ShareBasedCompensation
3932000
us-gaap Share Based Compensation
ShareBasedCompensation
3556000
us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
7781000
us-gaap Increase Decrease In Derivative Assets And Liabilities
IncreaseDecreaseInDerivativeAssetsAndLiabilities
-2559000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-13631000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-10090000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-258000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
652000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1725000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
467000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3302000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2541000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-464000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
232000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-20000
us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
18000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-11042000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
20717000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-17609000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
19760000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
212000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
106000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
43275000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
88951000
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
13234000
us-gaap Operating Expenses
OperatingExpenses
27533000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
104000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
59000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
328116000
us-gaap Operating Income Loss
OperatingIncomeLoss
-18250000
CY2013Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
34000
us-gaap Net Income Loss
NetIncomeLoss
-20826000
us-gaap Operating Income Loss
OperatingIncomeLoss
-23700000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
97000
us-gaap Net Income Loss
NetIncomeLoss
-15620000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59232611
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59232611
us-gaap Contracts Revenue
ContractsRevenue
11041000
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1193000
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6350000
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8906000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7947000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
28000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-351678000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-23475000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
104118000
CY2014Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4142000
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7444000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27016000
CY2014Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
6564000
CY2013Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
23421000
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
76916000
CY2014Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-341000
CY2013Q3 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
6379000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-15822000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-20705000
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-202000
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-7745000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
1176000
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-13000
CY2013Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
65000
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7758000
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1241000
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59845000
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58542000
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61494000
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63561000
CY2014Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
57279000
CY2014Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
13000
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4806759
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
3203000
us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
46715000
us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
56797000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
16462000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-29057000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5108000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2269000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5108000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2269000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3961000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7028000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11029000
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4001000
CY2014Q3 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
-1558000
CY2013Q3 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
-6379000
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
-7781000
us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
-557000
CY2014Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-9303000
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5203000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-23401000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-21383000
CY2014Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1649000
CY2013Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
5019000
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
3919000
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
2509000
CY2014Q3 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
3700000
us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
11000000
CY2013Q3 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
3200000
us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
9300000
CY2014Q3 us-gaap Recovery Of Direct Costs
RecoveryOfDirectCosts
4800000
us-gaap Recovery Of Direct Costs
RecoveryOfDirectCosts
14200000
CY2013Q3 us-gaap Recovery Of Direct Costs
RecoveryOfDirectCosts
5500000
us-gaap Recovery Of Direct Costs
RecoveryOfDirectCosts
11600000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4400000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
9076000
CY2014Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
9076000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7781000
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1198000
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1231000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3932000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3556000
CY2014Q3 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
17000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
73000
CY2013Q3 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
36000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
100000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6526506
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1835250
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
67303
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
121593
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8172860
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
8096147
CY2013Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
82033000
CY2014Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
17000
CY2014Q3 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.66
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.81
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.43
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.67
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.70
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.69
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.14
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y5M5D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y4M28D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y6M11D
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6734462
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
6731205
CY2014Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
6278785
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
200000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
500000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
200000
CY2014Q3 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
68305000
CY2014Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
57283000
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
74726000
CY2013Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
38000
CY2013Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
10000
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
74754000
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0
CY2013Q3 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0
thld Weighted Average Maturity For Available For Sale Securities
WeightedAverageMaturityForAvailableForSaleSecurities
P5M21D
CY2014Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
24961000
CY2014Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
13000
CY2014Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4600000
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
225000
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
918000
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
953000
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
238000
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
0
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2334000

Files In Submission

Name View Source Status
0001564590-14-004836-index-headers.html Edgar Link pending
0001564590-14-004836-index.html Edgar Link pending
0001564590-14-004836.txt Edgar Link pending
0001564590-14-004836-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
thld-10q_20140930.htm Edgar Link pending
thld-20140930.xml Edgar Link completed
thld-20140930.xsd Edgar Link pending
thld-20140930_cal.xml Edgar Link unprocessable
thld-20140930_def.xml Edgar Link unprocessable
thld-20140930_lab.xml Edgar Link unprocessable
thld-20140930_pre.xml Edgar Link unprocessable
thld-ex31_201409306.htm Edgar Link pending
thld-ex31_201409309.htm Edgar Link pending
thld-ex32_2014093010.htm Edgar Link pending
thld-ex32_201409307.htm Edgar Link pending